RE:Friday could be a bottomCame here to post that lowering of drug costs will not prove to be such a factor in USA and basically unaffected in Europe (gee, doesn't Sintrom sell for 7c a dose and, more than this, the other newer blood thinners are running into litigation in USA as well as having MUCH higher selling price. Only Enablex outcome is uncertain.)
Must add however i do not see logic in first post on this subject for if dollar cost averaging from pp then surely the investors would be buying. Okay, so they might sell volume and force price lower to buy again at even lower levels, but otherwise don't get it.
MSL is suffering from that financing and then having no acqun opportunity immediately or even in short term and the general market malaise for health/bio in particular.
GLA